Ketamine as a New Standard for Sedation
Ketamine represents a viable, safe alternative to traditional opioid-benzodiazepine sedation during interventional radiology procedures, according to a recent randomized clinical trial. Published in the journal Radiology, the study indicates that patients receiving ketamine experienced better pain control and fewer respiratory events compared to the current standard of care. This finding challenges long-standing practices in image-guided medicine where opioid reliance often poses significant risks like hypoxemia.
Lead author Amy R. Deipolyi, an interventional radiology specialist at the West Virginia University School of Medicine, headed the research team. They observed patients undergoing bone biopsies, lung biopsies, and abscess drainage procedures. The investigators sought to address the limitations of the typical fentanyl-midazolam regimen, which frequently results in complications related to respiratory depression. By shifting the sedation protocol, clinicians may improve both safety and patient outcomes in complex, image-guided interventions.
Data and Patient Outcomes
Between 2025 and 2026, the team randomized 264 procedures involving 260 adult participants. Subjects were split into two cohorts to compare the efficacy of fentanyl against ketamine. The data revealed that ketamine provided superior analgesia. Specifically, the average pain score reduction reached 1.4 points in the ketamine group compared to the fentanyl cohort. Severe intraprocedural pain, defined as a score greater than 4, occurred in only 2.3% of ketamine cases versus 17% for those treated with fentanyl.
Respiratory safety markers also tilted in favor of the newer approach. Oxygen desaturation below 90% occurred in 2.3% of ketamine administrations, whereas the fentanyl group saw a 9.8% incidence rate. Beyond safety, patients reported higher levels of procedural comfort and less recall of the medical event. These findings suggest that the alternative drug profile aligns with the medical field’s broader shift toward minimizing unnecessary opioid exposure.
Industry Impact and Future Directions
Experts at Johns Hopkins Hospital reviewed the findings and emphasized that the results warrant immediate attention from radiology leadership. Clifford R. Weiss and Lauren S. Park, in a published editorial, noted that the near-elimination of moderate to severe pain is a significant clinical milestone. They warned that ketamine is not a total solution for every patient, as potential side effects like visual hallucinations, delirium, and dysphoria remain possibilities that require careful monitoring.
Despite the need for caution, the editorialists argued that the current reliance on legacy sedation methods restricts the operational flexibility of modern interventional practices. By adopting alternative protocols, radiologists can push the boundaries of what is possible in image-guided therapeutics. The medical community must now weigh these trial results against local clinical standards. Moving forward, the focus will likely turn toward establishing consistent guidelines for ketamine use, ensuring that the benefits of improved analgesia and safety are maintained across diverse hospital systems. This transition represents a necessary evolution in patient-centered procedural care.